ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2604

Ankylosing Spondylitis and Non- Radiographic Axial Spondyloarthritis :      the Same Syndrome or Different Diseases? Analysis from Esperanza Cohort

Azucena Hernández-Sanz1, Victoria Navarro-Compán2, Cristina Fernández-Carballido3, Carlos Montilla-Morales4, Juan Mulero5 and Eugenio De Miguel6, 1H. Virgen de la Salud, Toledo, Spain, 2Rheumatology, University Hospital La Paz, Madrid, Spain, 3Rheumatology, University General Hospital Elda, Elda (Alicante), Spain, 4H. de Salamanca, Salamanca, Spain, 5Rheumatology, University Hospital Puerta de Hierro, Majadahonda (Madrid), Spain, 6Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: AS, axial spondyloarthritis, non-radiographic and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose

New ASAS criteria for axial spondyloarthritis (axSpA) have two entrances: the imaging and clinical arm (presence of HLA B27). The imaging arm allows classifying patients as non radiolographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS).

The importance of the concept of nr-axSpA or the clinic arm in the classification of SpA is questioned currently, so it is interesting to investigate how homogeneous or different populations are compared to the classical AS.

Prymary objetive was to compare the characteristics of AS and nr-axSpA of recent onset. Secondary one was to compare the characteristics between groups axial SpA diagnosed by clinical and imaging arm.

Methods

Population: Baseline dataset from the ESPeranza cohort (<45 yrs, symptoms duration 3-24 months and with inflammatory  back pain -IBP- or asymmetrical arthritis or spinal/joint pain plus ≥1 SpA features).

Inclusión criteria: Patiens who met ASAS criteria  for axSpA.

Variables: Demographic, clinical, activity indices (BASDAI and CRP), mobility (BASMI) and physical function (BASFI) were compared.

Statistical analysis: Results are presented in mean ± standard deviation for continuous variables and n,(%) for categorical variables

Results 

A total of 775 patients were included in the “ESperanza” program- From these, 291 met ASAS criteria for axSpA: 194 imaging arm (43.8% nr-axSpA and 56.2 % EA), and 97 clinical arm.

Sixty five percent were male with a mean age of 32 ± 7 years and mean disease duration of 13 ± 6.7 months. Males were more frequently observed in patients with AS compared to nr-axSpA group. Only diarrhea and genito-urinary disease were more frequent in the group of nr-axSpA (Table). Mobility was more impaired in the AS group. No significant differences in the activity or other baseline characteristics were observed. Peripheral and genito-urinary disease, arthritis, enthesitis, uveitis, diarrhea, and family history were significantly more frequent in patients in the clinical arm, while physical function was more impaired in patients on image arm.

Conclusion

Patients with nr-axSpA have very similar clinical features to AS patients in the early stages of the disease, except higher frequency of males and mobility limitation in the AS group.

Patients with axial axSpA in the clinical arm presented more often peripheral involvement that the imaging arm, while no significant differences in the presence of psoriasis and inflammatory bowel disease and activity rates.


Disclosure:

A. Hernández-Sanz,
None;

V. Navarro-Compán,
None;

C. Fernández-Carballido,
None;

C. Montilla-Morales,
None;

J. Mulero,
None;

E. De Miguel,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ankylosing-spondylitis-and-non-radiographic-axial-spondyloarthritis-the-same-syndrome-or-different-diseases-analysis-from-esperanza-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology